Why Google Stock Is Still An Undisputed IPO Benchmark To Learn From
Investors· 2026-02-27 22:33
Core Viewpoint - The article discusses how Google's IPO created optimal technical conditions for traders to evaluate new market debuts [1] Group 1 - Google's IPO is highlighted as a benchmark for assessing future IPOs due to its favorable market conditions [1] - The technical indicators from Google's IPO can serve as a model for traders to filter and identify potential investment opportunities in upcoming IPOs [1] - The article emphasizes the importance of analyzing technical conditions in the context of new market entries, using Google's IPO as a case study [1]
Securitize's Explosive Growth and the $SLINK Narrative Play Positioning Retail Early in the RWA Revolution
Globenewswire· 2026-02-27 22:31
New York, NY, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Tokenization is no longer a future concept. It is the infrastructure upgrade that is reshaping global finance today. Trillions in real-world assets — real estate, private credit, funds, equities and more — are moving on-chain. Leading this shift is Securitize, the institutional-grade tokenization platform powering BlackRock’s BUIDL fund, partnering with major banks and asset managers, and executing landmark deals such as tokenized luxury resorts. In the first ...
ROSEN, TOP RANKED GLOBAL INVESTOR COUNSEL, Encourages Oracle Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – ORCL
Globenewswire· 2026-02-27 22:31
Core Viewpoint - A class action lawsuit has been filed against Oracle Corporation for alleged misleading statements regarding its AI infrastructure strategy and its financial implications during the Class Period from June 12, 2025, to December 16, 2025 [1][5]. Group 1: Lawsuit Details - The lawsuit claims that Oracle's AI infrastructure strategy would lead to significant increases in capital expenditures without corresponding near-term revenue growth [5]. - It is alleged that Oracle's increased spending poses risks to its debt, credit rating, free cash flow, and project funding capabilities [5]. - The lawsuit asserts that the defendants' statements about Oracle's business and prospects were materially false and misleading, resulting in investor damages when the true information became public [5]. Group 2: Participation Information - Investors who purchased Oracle common stock during the Class Period may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - To join the class action, interested parties can visit the provided link or contact the law firm directly for more information [3][6]. - A lead plaintiff must file a motion with the Court by April 6, 2026, to represent other class members in the litigation [1][3]. Group 3: Law Firm Credentials - The Rosen Law Firm has a strong track record in securities class actions, having achieved significant settlements, including the largest securities class action settlement against a Chinese company [4]. - The firm has been consistently ranked among the top firms for securities class action settlements and has recovered hundreds of millions of dollars for investors [4]. - In 2019, the firm secured over $438 million for investors, highlighting its effectiveness in representing shareholder interests [4].
Nasdaq (NDAQ) Launches New Private Capital Indexes to Standardize Benchmarking for Private Markets
Insider Monkey· 2026-02-27 22:30
Core Insights - Generative AI is viewed as a transformative technology by Amazon's CEO Andy Jassy, indicating its potential to reinvent customer experiences [1] - Elon Musk predicts that humanoid robots could create a market worth $250 trillion by 2040, reshaping the global economy [2] - Major firms like PwC and McKinsey acknowledge that AI could unlock multi-trillion-dollar potential, supporting Musk's ambitious forecast [3] Industry Trends - The AI revolution is characterized by a powerful breakthrough that is redefining work, learning, and creativity, attracting significant interest from hedge funds and top investors [4] - A smaller, under-owned company is identified as holding the key to the AI revolution, suggesting potential investment opportunities [4][6] - Prominent figures in technology and finance, including Bill Gates and Warren Buffett, recognize AI as a major technological advancement with the potential for significant social impact [8] Investment Opportunities - There is a belief that investors may regret not owning certain stocks related to AI advancements in the near future [9] - A detailed report on a groundbreaking AI company is available, highlighting its technology and growth potential [10] - Subscription to a premium newsletter offers access to exclusive insights and stock picks related to the AI sector, emphasizing the urgency of capitalizing on these opportunities [12][13]
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Corcept Therapeutics Incorporated to Secure Counsel Before Important Deadline in Securities Class Action – CORT
Globenewswire· 2026-02-27 22:30
Core Viewpoint - Rosen Law Firm has announced a class action lawsuit on behalf of purchasers of common stock of Corcept Therapeutics Incorporated during the specified Class Period, indicating potential legal issues surrounding the company's stock performance and regulatory challenges [1][5]. Group 1: Class Action Details - The class action lawsuit is on behalf of investors who purchased Corcept common stock between October 31, 2024, and December 30, 2025 [1]. - Investors may be entitled to compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - Interested parties can join the class action by submitting a form or contacting the law firm directly [3][6]. Group 2: Legal Representation - Rosen Law Firm emphasizes the importance of selecting qualified legal counsel with a successful track record in securities class actions [4]. - The firm has achieved significant settlements in the past, including over $438 million for investors in 2019, and has been recognized for its performance in securities class action settlements [4]. Group 3: Case Background - The lawsuit claims that Corcept misrepresented the strength of clinical trials supporting the New Drug Application (NDA) for relacorilant, suggesting confidence in FDA approval despite known concerns from the FDA regarding clinical evidence [5]. - The defendants allegedly communicated misleading information to investors about the likelihood of NDA approval, leading to investor damages when the truth was revealed [5].
OpGen, Inc. (OTC: OPGN) Announces Name Change to CapForce Inc.
Globenewswire· 2026-02-27 22:30
Core Perspective - OpGen, Inc. has rebranded itself as CapForce Inc. to align with its new focus on digital investment banking and financial technology sectors [1] Company Overview - CapForce Inc. provides fintech-enabled digital investment banking services targeting global high-growth mid-sized private companies with market capitalizations between $1 billion and $10 billion [2] - The company aims to serve small-cap and mid-cap stocks that are often overlooked by larger investment banks [2] - CapForce is developing a digital investment banking platform that includes AI-powered asset and wealth management services, cross-border securities activities, and technology-driven capitalization table management solutions [2] - The controlling shareholder, AEI Capital Group, manages over $7 billion in assets under management and focuses on global growth equity strategies [2]
Pulsar Helium Announces Closing of Fundraise
Globenewswire· 2026-02-27 22:30
Core Viewpoint - Pulsar Helium Inc. has conditionally closed a placing of 9,191,175 common shares at a price of £0.80 per share, raising total gross proceeds of approximately £7.35 million (around US$10 million / CAD$13.7 million) to advance its helium projects [1][2]. Group 1: Financial Details - The placing was priced at £0.80 per share, resulting in gross proceeds of £7,352,940 [1]. - The net proceeds will be utilized for the Topaz helium project in Minnesota, the Falcon project in Michigan, and for general working capital [2]. - An advisory fee of £20,000 and a cash fee of £441,176 were paid to OAK Securities in connection with the placing [3]. Group 2: Project Development - The funds from the placing will support extended well testing, reservoir evaluation, and an additional seismic survey at the Topaz Project [2]. - The company plans to consolidate and expand its mineral and leasehold interests, update the independent resource estimate, and complete a pre-feasibility study for integrated helium and CO₂ production [2]. - A portion of the proceeds will also support exploration activities at the Falcon Project [2]. Group 3: Company Overview - Pulsar Helium Inc. is publicly traded on the AIM market of the London Stock Exchange and listed on the TSX Venture Exchange and OTCQB [9]. - The company focuses on helium projects, with its flagship Topaz project in Minnesota and the Falcon project in Michigan, both identified as primary helium occurrences not associated with hydrocarbon production [9].
Pond Technologies Holdings Inc. Provides Update on Transaction with Find Familiar Spirits
Thenewswire· 2026-02-27 22:30
Core Viewpoint - Pond Technologies Holdings Inc. has extended the deadline to enter into a definitive agreement for a reverse takeover transaction with Find Familiar Spirits LLC to May 31, 2026, after initially announcing the signing of a binding letter of intent on October 28, 2026 [1] Group 1 - The Proposed Transaction involves a business combination where Pond will acquire FFS [1] - The extension of the deadline allows more time for the parties to finalize the agreement [1] - If the definitive agreement is not executed by the new deadline, the letter of intent may be terminated [1] Group 2 - Completion of the Proposed Transaction is subject to several conditions, including regulatory approvals and a concurrent financing [2] - There is no assurance that the Proposed Transaction will be completed as proposed or at all [2] Group 3 - Investors are advised that information regarding the Proposed Transaction may not be accurate or complete unless disclosed in the management information circular or filing statement [3] - The TSX Venture Exchange has not approved or disapproved the contents of the news release [3] Group 4 - The news release contains forward-looking information regarding the Proposed Transaction and associated transactions [4] - Statements about the completion and expected terms of the Proposed Transaction involve risks and uncertainties that may lead to different actual results [4]
Pulsar Helium Announces Closing of Fundraise
Globenewswire· 2026-02-27 22:30
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN, INTO OR FROM AUSTRALIA, JAPAN OR THE REPUBLIC OF SOUTH AFRICA OR TO BE TRANSMITTED, DISTRIBUTED TO, OR SENT BY, ANY NATIONAL OR RESIDENT OR CITIZEN OF ANY SUCH COUNTRIES OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION MAY CONTRAVENE LOCAL SECURITIES LAWS OR REGULATIONS. NOT FOR DISTRIBUTION TO UNITED STATES NEW ...
Avalon GloboCare Announces Closing of up to $9.75 Million Private Placement Priced At-the-Market under Nasdaq Rules
Globenewswire· 2026-02-27 22:30
Core Viewpoint - Avalon GloboCare Corp. has successfully closed a private placement, raising approximately $3.25 million, with potential additional proceeds of up to $6.5 million from warrants [1][3]. Group 1: Financial Details - The private placement involved the issuance and sale of 6,372,550 shares of common stock at a purchase price of $0.51 per share, along with Series A-1 and A-2 warrants [1]. - The gross proceeds from the offering were approximately $3.25 million before deducting fees and expenses, with potential additional gross proceeds of approximately $6.5 million if the warrants are fully exercised [3]. - The net proceeds from the offering will be used for debt repayment, working capital, and general corporate purposes [3]. Group 2: Warrants Information - Series A-1 warrants will expire five years from stockholder approval, while Series A-2 warrants will expire eighteen months from stockholder approval [1]. - The warrants have an exercise price of $0.51 per share and will be exercisable upon stockholder approval [1]. Group 3: Company Overview - Avalon GloboCare Corp. is focused on developing precision diagnostic consumer products and generative AI publishing and software [1]. - The company is advancing AI systems through its subsidiary, Avalon Quantum AI LLC, and is expanding its intellectual property in cellular therapy and generative AI [6]. - Avalon is also marketing the KetoAir™ breathalyzer device, registered as a Class I medical device with the FDA, and plans to pursue additional diagnostic applications [6].